X-8465851-G-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001001888.4(VCX3B):​c.209G>T​(p.Gly70Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0 ( 0 hom., 0 hem., cov: 11)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

VCX3B
NM_001001888.4 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.22
Variant links:
Genes affected
VCX3B (HGNC:31838): (variable charge X-linked 3B) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes, and all are expressed exclusively in male germ cells. The X-linked members are clustered on chromosome Xp22, and the Y-linked members are two identical copies of the gene within a palindromic region on chromosome Yq11. The family members share a high degree of sequence identity, with the exception that a 30-nt unit is tandemly repeated in X-linked members but occurs only once in Y-linked members. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This family member, as represented by the reference genome allele, contains 14 copies of the 30-nt repeat unit. VCX/Y genes encode small and highly charged proteins containing putative bipartite nuclear localization signals. Although the exact function of this family member has yet to be determined, a role in mRNA stability regulation can be inferred from the ability of the highly similar family member, VCX-A, to inhibit mRNA decapping. A possible role in the regulation of ribosome assembly during spermatogenesis has also been suggested. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09262064).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VCX3BNM_001001888.4 linkuse as main transcriptc.209G>T p.Gly70Val missense_variant 3/3 ENST00000381032.6 NP_001001888.3 Q9H321-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VCX3BENST00000381032.6 linkuse as main transcriptc.209G>T p.Gly70Val missense_variant 3/35 NM_001001888.4 ENSP00000370420.1 Q9H321-1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
73034
Hom.:
0
Cov.:
11
AF XY:
0.00
AC XY:
0
AN XY:
13140
FAILED QC
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
987688
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
297232
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
73053
Hom.:
0
Cov.:
11
AF XY:
0.00
AC XY:
0
AN XY:
13169
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 28, 2022The c.209G>T (p.G70V) alteration is located in exon 3 (coding exon 2) of the VCX3B gene. This alteration results from a G to T substitution at nucleotide position 209, causing the glycine (G) at amino acid position 70 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
13
DANN
Benign
0.88
DEOGEN2
Benign
0.015
.;T;.;.
FATHMM_MKL
Benign
0.072
N
LIST_S2
Benign
0.70
T;T;T;T
M_CAP
Benign
0.0052
T
MetaRNN
Benign
0.093
T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Uncertain
2.2
.;M;.;.
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.1
N;N;N;N
REVEL
Benign
0.041
Sift
Uncertain
0.0040
D;D;D;D
Sift4G
Uncertain
0.016
D;D;D;T
Polyphen
1.0
.;D;.;.
Vest4
0.056
MutPred
0.21
Loss of glycosylation at S69 (P = 0.0514);Loss of glycosylation at S69 (P = 0.0514);Loss of glycosylation at S69 (P = 0.0514);Loss of glycosylation at S69 (P = 0.0514);
MVP
0.076
MPC
1.1
ClinPred
0.31
T
GERP RS
0.68
Varity_R
0.12
gMVP
0.0065

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761128041; hg19: chrX-8433892; API